本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Recursion Pharmaceuticals, Inc.

5.49
+0.920020.13%
盤後5.570.0800+1.46%19:59 EDT
成交量:6,032.27萬
成交額:3.19億
市值:22.34億
市盈率:-3.02
高:5.52
開:4.72
低:4.71
收:4.57
資料載入中...
2024/09/03

重要事件披露

Form 8-K - Current report
2024/08/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/28

重要事件披露

Form 8-K - Current report
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/15

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/08

重要事件披露

Form 8-K - Current report
2024/08/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/06

重要事件披露

Form 8-K - Current report
2024/07/25

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/23

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/09

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/08

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors